Last reviewed · How we verify

NCT07199075: Fibergraft

Rate of Bone Union After Surgery With Stand-alone Fibergraft

Not yet recruiting Last updated 30 September 2025
What this trial tests

trial testing Questionnaires in Spine Degeneration in 80 participants. Not yet recruiting.

Timeline
31 October 2025
Primary endpoint
30 May 2026
30 May 2026

Quick facts

Lead sponsorAO Innovation Translation Center
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment80
Start date31 October 2025
Primary completion30 May 2026
Estimated completion30 May 2026
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

AO Innovation Translation Center

Who can join

18 and older, any sex, with Spine Degeneration or Spine Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Some people have back problems caused by degenerative conditions or instability of the spine (eg. Spondylolisthesis). These problems can lead to pain, nerve issues, or difficulties in walking. A common treatment is a type of back surgery called lumbar interbody fusion, which helps stabilize the spine. At the St. Maartenskliniek in the Netherlands, doctors have been using a special material called Fibergraft Bioactive Glass Putty for such surgeries since 2023. This material helps bones grow and heal, and it's placed inside the spine without needing extra bone from another part of the body. This study will look at how well this material works by evaluating how many patients' bones successfully healed after surgery using this material. It will also look at how patients feel and recover after the procedure

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaires

Trials testing the same drug.

Other recruiting trials for Spine Degeneration

Currently open trials in the same condition.

Other AO Innovation Translation Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07199075.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing